Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Researchers report details of new studies and findings in the area of Cancer Therapy
January 12th, 2006
Cancer Therapy data are the focus of recent research from Switzerland, Italy and Taiwan. Study 1: Anthracyclines plus fluoropyrimidines were well tolerated and active in advanced breast cancer (ABC) patients. "The efficacy and safety of prolonged fluoropyrimidines, either intravenously or orally, prompted their integration with taxanes and anthracyclines in the treatment of ABC. We conducted three subsequent dose-finding studies on first-line chemotherapy in ABC with anthracyclines, either epirubicin (E) or doxorubicin (A), and docetaxel (T), both given on days 1 and 8 every 3 weeks, plus continuous infusion (CI) 5-fluorouracil (F) or capecitabine...
Source: Women's Health Weekly (2006-01-12)
|
